Iizasa T - Search Results

1

Exclusive mutation in epidermal growth factor receptor gene, HER-2, and KRAS, and synchronous methylation of nonsmall cell lung cancer.

Suzuki M, Shigematsu H, Iizasa T, Hiroshima K, Nakatani Y, Minna JD, Gazdar AF, Fujisawa T. Suzuki M, et al. Among authors: iizasa t. Cancer. 2006 May 15;106(10):2200-7. doi: 10.1002/cncr.21853. Cancer. 2006. PMID: 16598760 Free article.

2

Human monoclonal antibody detects a cell surface antigen expressed on hematopoietic malignant cells of lymphoid lineage.

Iizasa T, Yamaguchi Y, Tagawa M, Fujisawa T, Saito H, Kondo H, Matsuo Y, Minowada J, Taniguchi M. Iizasa T, et al. Jpn J Cancer Res. 1991 Feb;82(2):213-8. doi: 10.1111/j.1349-7006.1991.tb01831.x. Jpn J Cancer Res. 1991. PMID: 1900825 Free PMC article.

3

[Results of noncurative resection of primary lung cancer (II): Comparative study of the former (1952-1978) and latter (1979-1988) period].

Kimura H, Yamaguchi Y, Baba M, Kawano Y, Urabe N, Saitoh Y, Iizasa T, Odaka E, Suzuki M. Kimura H, et al. Among authors: iizasa t. Nihon Kyobu Geka Gakkai Zasshi. 1991 Mar;39(3):262-5. Nihon Kyobu Geka Gakkai Zasshi. 1991. PMID: 2051082 Japanese.

4

Establishment of human monoclonal antibody recognizing a new tumor-associated antigen from a patient with small cell lung carcinoma.

Iizasa T, Yamaguchi Y, Tagawa M, Saito H, Fujisawa T, Kato K, Taniguchi M. Iizasa T, et al. Hybridoma. 1990 Jun;9(3):211-9. doi: 10.1089/hyb.1990.9.211. Hybridoma. 1990. PMID: 2163975

5

Factors influencing survival following pulmonary resection for metastatic colorectal carcinoma.

Fujisawa T, Yamaguchi Y, Saitoh Y, Sekine Y, Iizasa T, Mitsunaga S, Hiroshima K, Ohwada H. Fujisawa T, et al. Among authors: iizasa t. Tohoku J Exp Med. 1996 Oct;180(2):153-60. doi: 10.1620/tjem.180.153. Tohoku J Exp Med. 1996. PMID: 9111764 Free article.

6

Serum anti-p53 autoantibodies in primary resected non-small-cell lung carcinoma.

Iizasa T, Fujisawa T, Saitoh Y, Hiroshima K, Ohwada H. Iizasa T, et al. Cancer Immunol Immunother. 1998 Aug;46(6):345-9. doi: 10.1007/s002620050496. Cancer Immunol Immunother. 1998. PMID: 9756419 Free PMC article.

7

Elevated levels of circulating plasma matrix metalloproteinase 9 in non-small cell lung cancer patients.

Iizasa T, Fujisawa T, Suzuki M, Motohashi S, Yasufuku K, Yasukawa T, Baba M, Shiba M. Iizasa T, et al. Clin Cancer Res. 1999 Jan;5(1):149-53. Clin Cancer Res. 1999. PMID: 9918213

8

Prognostic factors in surgical treatment of solitary brain metastasis after resection of non-small-cell lung cancer.

Saitoh Y, Fujisawa T, Shiba M, Yoshida S, Sekine Y, Baba M, Iizasa T, Kubota M. Saitoh Y, et al. Among authors: iizasa t. Lung Cancer. 1999 May;24(2):99-106. doi: 10.1016/s0169-5002(99)00034-3. Lung Cancer. 1999. PMID: 10444060

9

Expression of matrix metalloproteinases and tissue inhibitor of matrix metalloproteinases in non-small-cell lung cancer.

Suzuki M, Iizasa T, Fujisawa T, Baba M, Yamaguchi Y, Kimura H, Suzuki H. Suzuki M, et al. Among authors: iizasa t. Invasion Metastasis. 1998-1999;18(3):134-41. doi: 10.1159/000024506. Invasion Metastasis. 1998. PMID: 10474026

10

Antitumor cytotoxicity mediated by ligand-activated human V alpha24 NKT cells.

Kawano T, Nakayama T, Kamada N, Kaneko Y, Harada M, Ogura N, Akutsu Y, Motohashi S, Iizasa T, Endo H, Fujisawa T, Shinkai H, Taniguchi M. Kawano T, et al. Among authors: iizasa t. Cancer Res. 1999 Oct 15;59(20):5102-5. Cancer Res. 1999. PMID: 10537282

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

171 results

Search Page

Filters